New insider Neville Everett claimed ownership of 3,509 shares (SEC Form 3)
$CI
Medical Specialities
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/31/2025 |
3. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, $.01 Par Value | 3,509 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (Right to Buy) | 03/01/2023(1) | 02/23/2032 | Common Stock, $.01 Par Value | 3,622 | $227.02 | D | |
| Employee Stock Option (Right to Buy) | 03/01/2024(2) | 02/22/2033 | Common Stock, $.01 Par Value | 4,391 | $294.61 | D | |
| Employee Stock Option (Right to Buy) | 03/01/2026(3) | 02/28/2035 | Common Stock, $.01 Par Value | 6,386 | $305.855 | D | |
| Employee Stock Option (Right to Buy) | 03/01/2025(4) | 02/28/2034 | Common Stock, $.01 Par Value | 6,091 | $336.475 | D | |
| Phantom Stock Units | (5) | (5) | Common Stock, $.01 Par Value | 11,728.9306 | $0.0000(6) | D | |
| Explanation of Responses: |
| 1. This option is fully vested. |
| 2. This option was granted on February 22, 2023 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2024 and March 1, 2025, and the last installment becomes exercisable on March 1, 2026. |
| 3. This option vests in three equal annual installments beginning March 1, 2026. |
| 4. This option was granted on February 28, 2024, and vests in three equal annual installments. The first installment became exercisable on March 1, 2025, and the next two installments become exercisable on March 1, 2026 and March 1, 2027. |
| 5. Phantom stock units are payable in cash in accordance with the terms of the Express Scripts, Inc. Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. |
| 6. Represents phantom stock units under The Cigna Group stock fund of the Express Scripts, Inc. Executive Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group common stock and is to be settled in cash. |
| Remarks: |
| EVP, Strategy and Business Development Exhibit List: EX-24 Power of Attorney poaneville.txt |
| Tyler Gratton, attorney-in-fact | 04/09/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||